Form EFFECT Channel Therapeutics
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 2, 2024 |
| Accession Number: | 0001753926-24-001987 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Form-8.3 ADVANCED MEDICAL SOLUTIONS GROUP PLC - 12 10 2026 - (CGWL)
- FB Financial Corporation Reports Third Quarter 2026 Financial Results
- Medaro Mining Highlights High-Grade Rare Earth Mineralization at Bastnäs Project in Central Sweden, Including 32.99% Total Rare Earth Oxide & Strong Neodymium-Praseodymium Oxide Contribution
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share